5C6 Stock Overview
An investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Clearbridge Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.001 |
| 52 Week High | S$0.011 |
| 52 Week Low | S$0.001 |
| Beta | 0.59 |
| 11 Month Change | -60.00% |
| 3 Month Change | n/a |
| 1 Year Change | -88.24% |
| 33 Year Change | -98.86% |
| 5 Year Change | n/a |
| Change since IPO | -98.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5C6 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -33.3% | 0.3% | -1.3% |
| 1Y | -88.2% | 15.7% | 7.4% |
Return vs Industry: 5C6 underperformed the German Healthcare industry which returned 14.5% over the past year.
Return vs Market: 5C6 underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| 5C6 volatility | |
|---|---|
| 5C6 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5C6's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 5C6's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 121 | Jeremy Yee | www.clearbridgehealth.com |
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services.
Clearbridge Health Limited Fundamentals Summary
| 5C6 fundamental statistics | |
|---|---|
| Market cap | €1.32m |
| Earnings (TTM) | -€22.96m |
| Revenue (TTM) | €7.01m |
0.2x
P/S Ratio-0.1x
P/E RatioIs 5C6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5C6 income statement (TTM) | |
|---|---|
| Revenue | S$9.89m |
| Cost of Revenue | S$5.24m |
| Gross Profit | S$4.65m |
| Other Expenses | S$37.05m |
| Earnings | -S$32.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 47.02% |
| Net Profit Margin | -327.55% |
| Debt/Equity Ratio | 50.4% |
How did 5C6 perform over the long term?
See historical performance and comparison